Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Extremely preterm infants who develop bronchopulmonary dysplasia (BPD) are at a higher risk for adverse pulmonary and neurodevelopmental outcomes. In the National Institute of Child Health and Human Development Neonatal Research Network (NICHD NRN) Hydrocortisone Trial, hydrocortisone ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentle, Samuel J., Rysavy, Matthew A., Li, Lei, Laughon, Matthew M., Patel, Ravi M., Jensen, Erik A., Hintz, Susan, Ambalavanan, Namasivayam, Carlo, Waldemar A., Watterberg, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233424/
https://www.ncbi.nlm.nih.gov/pubmed/37256621
http://dx.doi.org/10.1001/jamanetworkopen.2023.15315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233424/
https://www.ncbi.nlm.nih.gov/pubmed/37256621
http://dx.doi.org/10.1001/jamanetworkopen.2023.15315

Ejemplares similares